All Stories

  1. Glioblastoma immune-related gene landscape and its prognostic significance identified with integrative multiomics

    Article • BMC Cancer, July 2026, Springer Science + Business Media

    Professor Xianquan Zhan

  2. Epigenetic Modifications are Instrumental for Improving Overall Research and Management of Osteosarcoma in the Framework of 3P Medicine

    Article • Journal of Neuro and Oncology Research, June 2026, Athenaeum Scientific Publishers

    Professor Xianquan Zhan

  3. Advancing predictive preventive personalized medicine for African health equity

    Article • Scientific African, June 2026, Elsevier

    Professor Xianquan Zhan

  4. Targeted proteoform degradation for precision drug design, delivery, and therapy

    Article • Drug Delivery, May 2026, Taylor & Francis

    Professor Xianquan Zhan

  5. Predictive, preventive, and personalized medicine for respiratory viral infections: Integration of mechanistic insights and precision interventions

    Article • Next Research, May 2026, Elsevier

    Professor Xianquan Zhan

  6. Abstract 3785 Proteoformics-guided innovative concept of personalized drug therapy

    Article • Journal of Biological Chemistry, May 2026, Elsevier

    Professor Xianquan Zhan

  7. Prevalence of RSV among patients in tertiary hospitals and healthcare worker knowledge in The Gambia: A paradigm shift from reactive to proactive 3PM-guided care is envisaged

    Article • International Journal of Infectious Diseases, April 2026, Elsevier

    Professor Xianquan Zhan

  8. Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

    Article • Journal of Visualized Experiments, March 2026, MyJove Corporation

    Professor Xianquan Zhan

  9. Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers

    Article • Journal of Ovarian Research, March 2026, Springer Science + Business Media

    Professor Xianquan Zhan

  10. Molecular Medicine - New Insights

    Article • February 2026, IntechOpen

    Professor Xianquan Zhan

  11. What does one-dimensional gel electrophoresis-based western blotting data really mean in the reality of proteoforms?

    Article • Talanta, December 2025, Elsevier

    Professor Xianquan Zhan

  12. Glioma angiogenesis phosphoproteome landscape and biomarker sets identified with phenome-centered multiomics toward 3P medical approaches

    Article • The EPMA Journal, November 2025, Springer Science + Business Media

    Professor Xianquan Zhan

  13. The use of predictive, preventive, and personalized medical approaches to optimize hypertension management

    Article • The EPMA Journal, October 2025, Springer Science + Business Media

    Professor Xianquan Zhan

  14. Proteoformics: Current status and future perspectives

    Article • Journal of Proteomics, October 2025, Elsevier

    Professor Xianquan Zhan

  15. Mitochondrial medicine: “from bench to bedside” 3PM-guided concept

    Article • The EPMA Journal, April 2025, Springer Science + Business Media

    Professor Xianquan Zhan

  16. Monoclonal antibody immune therapy response instrument for stratification and cost-effective personalized approaches in 3PM-guided pan cancer management

    Article • The EPMA Journal, March 2025, Springer Science + Business Media

    Professor Xianquan Zhan

  17. Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches

    Article • Metabolites, March 2025, MDPI AG

    Professor Xianquan Zhan

  18. Multiomics as instrument to promote 3P medical approaches for the overall management of respiratory syncytial viral infections

    Article • The EPMA Journal, January 2025, Springer Science + Business Media

    Professor Xianquan Zhan

  19. Big data for neuroscience in the context of predictive, preventive, and personalized medicine

    Article • The EPMA Journal, December 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  20. Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches

    Article • The EPMA Journal, November 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  21. Editorial: Biomolecular modifications in endocrine-related cancers, volume II

    Article • Frontiers in Endocrinology, October 2024, Frontiers

    Professor Xianquan Zhan

  22. Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged

    Article • The EPMA Journal, August 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  23. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach

    Article • The EPMA Journal, May 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  24. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach

    Article • The EPMA Journal, April 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  25. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine

    Article • The EPMA Journal, April 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  26. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach

    Article • The EPMA Journal, March 2024, Springer Science + Business Media

    Professor Xianquan Zhan

  27. Personalized Drug Therapy: Innovative Concept Guided With Proteoformics

    Article • Molecular & Cellular Proteomics, March 2024, Elsevier

    Professor Xianquan Zhan

  28. Modifications in Biomacromolecules

    Article • February 2024, IntechOpen

    Professor Xianquan Zhan

  29. Personalized Medicine - New Perspectives

    Article • February 2024, IntechOpen

    Professor Xianquan Zhan

  30. Editorial: Advances in approaches for function-preserving gastric cancer surgery

    Article • Frontiers in Surgery, January 2024, Frontiers

    Professor Xianquan Zhan

  31. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes

    Article • The EPMA Journal, December 2023, Springer Science + Business Media

    Professor Xianquan Zhan

  32. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer

    Article • Frontiers in Endocrinology, September 2023, Frontiers

    Professor Xianquan Zhan

  33. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach

    Article • The EPMA Journal, August 2023, Springer Science + Business Media

    Professor Xianquan Zhan

  34. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers

    Article • The EPMA Journal, June 2023, Springer Science + Business Media

    Professor Xianquan Zhan

  35. Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors

    Article • The EPMA Journal, June 2023, Springer Science + Business Media

    Professor Xianquan Zhan

  36. Mass spectrometry analysis of phosphotyrosine‐containing proteins

    Article • Mass Spectrometry Reviews, February 2023, Wiley

    Professor Xianquan Zhan

  37. Editorial: New molecular targets involved in lung adenocarcinoma

    Article • Frontiers in Endocrinology, January 2023, Frontiers

    Professor Xianquan Zhan

  38. Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer

    Article • Frontiers in Immunology, January 2023, Frontiers

    Professor Xianquan Zhan

  39. Editorial: Biomolecular modifications in endocrine-related cancers

    Article • Frontiers in Endocrinology, January 2023, Frontiers

    Professor Xianquan Zhan

  40. A Powerful Paradigm: Predictive, Preventive, and Personalized Medicine with Multiomics of Human Pituitary Adenomas

    Article • January 2023, Springer Science + Business Media

    Professor Xianquan Zhan

  41. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis

    Article • Frontiers in Endocrinology, December 2022, Frontiers

    Professor Xianquan Zhan

  42. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine

    Article • The EPMA Journal, November 2022, Springer Science + Business Media

    Professor Xianquan Zhan

  43. Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics

    Article • Frontiers in Endocrinology, September 2022, Frontiers

    Professor Xianquan Zhan

  44. The role of protein acetylation in carcinogenesis and targeted drug discovery

    Article • Frontiers in Endocrinology, September 2022, Frontiers

    Professor Xianquan Zhan

  45. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine

    Article • Frontiers in Endocrinology, August 2022, Frontiers

    Professor Xianquan Zhan

  46. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?

    Article • The EPMA Journal, June 2022, Springer Science + Business Media

    Professor Xianquan Zhan

  47. Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine

    Article • The EPMA Journal, May 2022, Springer Science + Business Media

    Professor Xianquan Zhan

  48. The comparison between 2DE‐MS and bottom‐up LC‐MS demands high‐end techniques for both technologies

    Article • Electrophoresis, April 2022, Wiley

    Professor Xianquan Zhan

  49. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine

    Article • The EPMA Journal, February 2022, Springer Science + Business Media

    Professor Xianquan Zhan

  50. Machine Learning Identifies Pan‐Cancer Landscape of Nrf2 Oxidative Stress Response Pathway‐Related Genes

    Article • Oxidative Medicine and Cellular Longevity, January 2022, Wiley

    Professor Xianquan Zhan

  51. Mitochondrial Dysfunction Pathway Alterations Offer Potential Biomarkers and Therapeutic Targets for Ovarian Cancer

    Article • Oxidative Medicine and Cellular Longevity, January 2022, Wiley

    Professor Xianquan Zhan

  52. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine

    Article • The EPMA Journal, December 2021, Springer Science + Business Media

    Professor Xianquan Zhan

  53. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

    Article • Frontiers in Immunology, November 2021, Frontiers

    Professor Xianquan Zhan

  54. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

    Article • Frontiers in Endocrinology, October 2021, Frontiers

    Professor Xianquan Zhan

  55. Quantitative Acetylomics Revealed Acetylation-Mediated Molecular Pathway Network Changes in Human Nonfunctional Pituitary Neuroendocrine Tumors

    Article • Frontiers in Endocrinology, October 2021, Frontiers

    Professor Xianquan Zhan

  56. Integrated genomic analysis of proteasome alterations across 11,057 patients with 33 cancer types: clinically relevant outcomes in framework of 3P medicine

    Article • The EPMA Journal, September 2021, Springer Science + Business Media

    Professor Xianquan Zhan

  57. Introductory Chapter: Metabolomics

    Article • September 2021, IntechOpen

    Professor Xianquan Zhan

  58. Metabolomics - Methodology and Applications in Medical Sciences and Life Sciences

    Article • September 2021, IntechOpen

    Professor Xianquan Zhan

  59. Phosphorylation-Mediated Molecular Pathway Changes in Human Pituitary Neuroendocrine Tumors Identified by Quantitative Phosphoproteomics

    Article • Cells, August 2021, MDPI AG

    Professor Xianquan Zhan

  60. The use of mass spectrometry in a proteome‐centered multiomics study of human pituitary adenomas

    Article • Mass Spectrometry Reviews, June 2021, Wiley

    Professor Xianquan Zhan

  61. Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas

    Article • Frontiers in Pharmacology, March 2021, Frontiers

    Professor Xianquan Zhan

  62. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches

    Article • The EPMA Journal, March 2021, Springer Science + Business Media

    Professor Xianquan Zhan

  63. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas

    Article • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, March 2021, Elsevier

    Professor Xianquan Zhan

  64. Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer

    Article • Frontiers in Genetics, February 2021, Frontiers

    Professor Xianquan Zhan

  65. The Anti-Cancer Effects of Anti-Parasite Drug Ivermectin in Ovarian Cancer

    Article • January 2021, IntechOpen

    Professor Xianquan Zhan

  66. Cell Culture: Advanced Technology and Applications in Medical and Life Sciences [Working Title]

    Article • January 2021, IntechOpen

    Professor Xianquan Zhan

  67. Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway‐Related Genes in Lung Cancers

    Article • Oxidative Medicine and Cellular Longevity, January 2021, Wiley

    Professor Xianquan Zhan

  68. HSP60 Regulates Lipid Metabolism in Human Ovarian Cancer

    Article • Oxidative Medicine and Cellular Longevity, January 2021, Wiley

    Professor Xianquan Zhan

  69. Ubiquitin - Proteasome Pathway

    Article • December 2020, IntechOpen

    Professor Xianquan Zhan

  70. Abnormal Ubiquitination of Ubiquitin-Proteasome System in Lung Squamous Cell Carcinomas

    Article • December 2020, IntechOpen

    Professor Xianquan Zhan

  71. SILAC quantitative proteomics analysis of ivermectin‐related proteomic profiling and molecular network alterations in human ovarian cancer cells

    Article • Journal of Mass Spectrometry, October 2020, Wiley

    Professor Xianquan Zhan

  72. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine

    Article • The EPMA Journal, October 2020, Springer Science + Business Media

    Professor Xianquan Zhan

  73. Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment

    Article • Journal of Cellular Physiology, September 2020, Wiley

    Professor Xianquan Zhan

  74. 10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020

    Article • The EPMA Journal, August 2020, Springer Science + Business Media

    Dr. Rostyslav V Bubnov, Professor Xianquan Zhan

  75. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas

    Article • The EPMA Journal, August 2020, Springer Science + Business Media

    Professor Xianquan Zhan

  76. Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine

    Article • The EPMA Journal, July 2020, Springer Science + Business Media

    Professor Xianquan Zhan

  77. Proteoforms - Concept and Applications in Medical Sciences

    Article • July 2020, IntechOpen

    Professor Xianquan Zhan

  78. Introductory Chapter: Proteoforms

    Article • July 2020, IntechOpen

    Professor Xianquan Zhan

  79. Prolactin Proteoform Pattern Changed in Human Pituitary Adenoma Relative to Control Pituitary Tissues

    Article • July 2020, IntechOpen

    Professor Xianquan Zhan

  80. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes

    Article • The EPMA Journal, May 2020, Springer Science + Business Media

    Professor Xianquan Zhan

  81. EDITORIAL: A SPECIAL ISSUE DEDICATED TO THE PROFESSIONAL CONTRIBUTIONS OF DOMINIC M. DESIDERIO

    Article • Mass Spectrometry Reviews, March 2020, Wiley

    Professor Xianquan Zhan

  82. Mitochondrial Proteomic and Molecular Network Alterations in Human Ovarian Cancers

    Article • March 2020, IntechOpen

    Professor Xianquan Zhan

  83. Editorial: Molecular Network Study of Pituitary Adenomas

    Article • Frontiers in Endocrinology, February 2020, Frontiers

    Professor Xianquan Zhan

  84. MASS SPECTROMETRY‐BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERS

    Article • Mass Spectrometry Reviews, February 2020, Wiley

    Professor Xianquan Zhan

  85. MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY

    Article • Mass Spectrometry Reviews, January 2020, Wiley

    Professor Xianquan Zhan

  86. Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas

    Article • The EPMA Journal, January 2020, Springer Science + Business Media

    Professor Xianquan Zhan

  87. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas

    Article • Frontiers in Endocrinology, December 2019, Frontiers

    Professor Xianquan Zhan

  88. Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients

    Article • Frontiers in Endocrinology, December 2019, Frontiers

    Professor Xianquan Zhan

  89. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles

    Article • The EPMA Journal, November 2019, Springer Science + Business Media

    Professor Xianquan Zhan

  90. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

    Article • Journal of Visualized Experiments, November 2019, MyJove Corporation

    Professor Xianquan Zhan

  91. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

    Article • Journal of Visualized Experiments, November 2019, MyJove Corporation

    Professor Xianquan Zhan

  92. Application of Two-Dimensional Gel Electrophoresis in Combination with Mass Spectrometry in the Study of Hormone Proteoforms

    Article • November 2019, IntechOpen

    Professor Xianquan Zhan

  93. Energy Metabolism Heterogeneity-Based Molecular Biomarkers for Ovarian Cancer

    Article • November 2019, IntechOpen

    Professor Xianquan Zhan

  94. Innovating the Concept and Practice of Two-Dimensional Gel Electrophoresis in the Analysis of Proteomes at the Proteoform Level

    Article • Proteomes, October 2019, MDPI AG

    Professor Xianquan Zhan

  95. Invasiveness-Related Proteomic Variations and Molecular Network Changes in Human Nonfunctional Pituitary Adenomas

    Article • September 2019, IntechOpen

    Professor Xianquan Zhan

  96. Recognition of Multiomics-Based Molecule-Pattern Biomarker for Precise Prediction, Diagnosis, and Prognostic Assessment in Cancer

    Article • September 2019, IntechOpen

    Professor Xianquan Zhan

  97. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas

    Article • The EPMA Journal, August 2019, Springer Science + Business Media

    Professor Xianquan Zhan

  98. Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer

    Article • The EPMA Journal, July 2019, Springer Science + Business Media

    Professor Xianquan Zhan

  99. Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics

    Article • The EPMA Journal, June 2019, Springer Science + Business Media

    Professor Xianquan Zhan

  100. Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas

    Article • Endocrine Related Cancer, October 2018, Bioscientifica

    Professor Xianquan Zhan

  101. The differentially mitochondrial proteomic dataset in human ovarian cancer relative to control tissues

    Article • Data in Brief, October 2018, Elsevier

    Professor Xianquan Zhan

  102. Protein Tyrosine Nitration in Lung Cancer: Current Research Status and Future Perspectives

    Article • Current Medicinal Chemistry, September 2018, Bentham Science Publishers

    Professor Xianquan Zhan

  103. The Use of Gel Electrophoresis and Mass Spectrometry to Identify Nitroproteins in Nervous System Tumors

    Article • September 2018, IntechOpen

    Professor Xianquan Zhan

  104. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application

    Article • Journal of Proteomics, September 2018, Elsevier

    Professor Xianquan Zhan

  105. Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified With Two-Dimensional Gel Electrophoresis and Mass Spectrometry

    Article • Frontiers in Endocrinology, August 2018, Frontiers

    Professor Xianquan Zhan

  106. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes

    Article • Gynecologic Oncology, August 2018, Elsevier

    Professor Xianquan Zhan

  107. Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome

    Article • Journal of Visualized Experiments, April 2018, MyJove Corporation

    Professor Xianquan Zhan

  108. The crucial role of multiomic approach in cancer research and clinically relevant outcomes

    Article • The EPMA Journal, February 2018, Springer Science + Business Media

    Professor Xianquan Zhan

  109. Every 2D spot contains over 50 to several hundreds of proteins - revival of 2DE-LC/MS in proteomics

    Article • Electrophoresis, February 2018, Wiley

    Professor Xianquan Zhan

  110. Revival of 2DE-LC/MS in Proteomics and Its Potential for Large-Scale Study of Human Proteoforms

    Article • Med One, January 2018, Qingres Limited

    Professor Xianquan Zhan

  111. EPMA World Congress: Traditional Forum in Predictive, Preventive and Personalised Medicine for Multi-Professional Consideration and Consolidation

    Article • The EPMA Journal, August 2017, Springer Science + Business Media

    Dr. Rostyslav V Bubnov, Professor Xianquan Zhan

  112. Pattern recognition for predictive, preventive, and personalized medicine in cancer

    Article • The EPMA Journal, March 2017, Springer Science + Business Media

    Professor Xianquan Zhan

  113. Editorial: Systems Biological Aspects of Pituitary Tumors

    Article • Frontiers in Endocrinology, June 2016, Frontiers

    Professor Xianquan Zhan

  114. Human Pituitary Adenoma Proteomics: New Progresses and Perspectives

    Article • Frontiers in Endocrinology, May 2016, Frontiers

    Professor Xianquan Zhan

  115. Exploration of Molecular Network Variations in Different Subtypes of Human Non-functional Pituitary Adenomas

    Article • Frontiers in Endocrinology, February 2016, Frontiers

    Professor Xianquan Zhan

  116. Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry

    Article • Journal of the American Society for Mass Spectrometry, October 2015, American Chemical Society (ACS)

    Professor Xianquan Zhan

  117. Proteomic and functional profiles of a follicle-stimulating hormone positive human nonfunctional pituitary adenoma

    Article • Electrophoresis, June 2015, Wiley

    Professor Xianquan Zhan

  118. EPMA position paper in cancer: current overview and future perspectives

    Article • The EPMA Journal, April 2015, Springer Science + Business Media

    Professor Xianquan Zhan, Dr. Rostyslav V Bubnov

  119. BMC Bioinformatics reviewer acknowledgement 2014

    Article • BMC Bioinformatics, March 2015, Springer Science + Business Media

    Professor Xianquan Zhan

  120. Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas

    Article • BMC Medical Genomics, December 2014, Springer Science + Business Media

    Professor Xianquan Zhan

  121. Identification of the proteomic variations of invasive relative to noninvasive nonfunctional pituitary adenomas

    Article • Electrophoresis, April 2014, Wiley

    Professor Xianquan Zhan

  122. Annual acknowledgement of reviewers

    Article • BMC Medical Genomics, February 2014, Springer Science + Business Media

    Professor Xianquan Zhan

  123. Multi-parameter systematic strategy opinion that predicts, prevents, and personalized treats a cancer

    Article • The EPMA Journal, February 2014, Springer Science + Business Media

    Professor Xianquan Zhan

  124. Mass spectrometry analysis of nitrotyrosine‐containing proteins

    Article • Mass Spectrometry Reviews, December 2013, Wiley

    Professor Xianquan Zhan

  125. Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line

    Article • BMC Cancer, November 2013, Springer Science + Business Media

    Professor Xianquan Zhan, Dr William C Cho

  126. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics

    Article • Electrophoresis, June 2013, Wiley

    Professor Xianquan Zhan

  127. Reviewer acknowledgement 2012

    Article • BMC Bioinformatics, April 2013, Springer Science + Business Media

    Professor Xianquan Zhan

  128. Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

    Article • The EPMA Journal, January 2013, Springer Science + Business Media

    Professor Xianquan Zhan

  129. Pituitary Adenoma Nitroproteomics: Current Status and Perspectives

    Article • Oxidative Medicine and Cellular Longevity, January 2013, Hindawi Publishing Corporation

    Professor Xianquan Zhan

  130. Mitochondrial proteomics of nasopharyngeal carcinoma metastasis

    Article • BMC Medical Genomics, December 2012, Springer Science + Business Media

    Professor Xianquan Zhan

  131. Identification of differentially expressed proteins in the spinal cord of neuropathic pain models with PKCgamma silence by proteomic analysis

    Article • Brain Research, February 2012, Elsevier

    Professor Xianquan Zhan

  132. Proteomic and Bioinformatics Analyses of Mouse Liver Microsomes

    Article • International Journal of Proteomics, January 2012, Hindawi Publishing Corporation

    Professor Xianquan Zhan

  133. The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas

    Article • The EPMA Journal, June 2010, Springer Science + Business Media

    Professor Xianquan Zhan

  134. Signaling pathway networks mined from human pituitary adenoma proteomics data

    Article • BMC Medical Genomics, April 2010, Springer Science + Business Media

    Professor Xianquan Zhan

  135. MALDI-induced fragmentation of leucine enkephalin, nitro-Tyr-leucine enkaphalin, and d5-Phe-nitro-Tyr-leucine enkephalin

    Article • International Journal of Mass Spectrometry, October 2009, Elsevier

    Professor Xianquan Zhan

  136. Detection of Nitrotyrosine-Containing Proteins

    Article • January 2009, Springer Science + Business Media

    Professor Xianquan Zhan

  137. Mass Spectrometric Identification of In Vivo Nitrotyrosine Sites in the Human Pituitary Tumor Proteome

    Article • January 2009, Springer Science + Business Media

    Professor Xianquan Zhan

  138. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses

    Article • Pituitary, January 2008, Springer Science + Business Media

    Professor Xianquan Zhan

  139. The human pituitary proteome: clinical applications

    Article • January 2008, Elsevier

    Professor Xianquan Zhan

  140. Linear ion-trap mass spectrometric characterization of human pituitary nitrotyrosine-containing proteins

    Article • International Journal of Mass Spectrometry, January 2007, Elsevier

    Professor Xianquan Zhan

  141. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry

    Article • Analytical Biochemistry, July 2006, Elsevier

    Professor Xianquan Zhan

  142. Proteomics analysis of growth hormone isoforms in the human pituitary

    Article • PROTEOMICS, April 2005, Wiley

    Professor Xianquan Zhan

  143. Comparative proteomics analysis of human pituitary adenomas: Current status and future perspectives

    Article • Mass Spectrometry Reviews, January 2005, Wiley

    Professor Xianquan Zhan

  144. The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry

    Article • Biochemical and Biophysical Research Communications, December 2004, Elsevier

    Professor Xianquan Zhan

  145. Heterogeneity Analysis of the Human Pituitary Proteome

    Article • Clinical Chemistry, October 2003, Oxford University Press (OUP)

    Professor Xianquan Zhan

  146. Comparative proteomics analysis of human lung squamous carcinoma

    Article • Biochemical and Biophysical Research Communications, September 2003, Elsevier

    Professor Xianquan Zhan

  147. Differences in the spatial and quantitative reproducibility between two second-dimensional gel electrophoresis systems

    Article • Electrophoresis, June 2003, Wiley

    Professor Xianquan Zhan

  148. Spot volume vs. amount of protein loaded onto a gel: A detailed, statistical comparison of two gel electrophoresis systems

    Article • Electrophoresis, June 2003, Wiley

    Professor Xianquan Zhan

  149. A reference map of a human pituitary adenoma proteome

    Article • PROTEOMICS, May 2003, Wiley

    Professor Xianquan Zhan

  150. Proteomics and Transcriptomics Analyses of Secretagogin Down-Regulation in Human Non-Functional Pituitary Adenomas

    Article • Pituitary, January 2003, Springer Science + Business Media

    Professor Xianquan Zhan